Neurocrine Biosciences (NBIX) Misses Q1 EPS by 5c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $161.44 -0.11%
EPS Growth %: -5.5%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -5.5%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of $0.49, $0.05 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $236.6 million versus the consensus estimate of $252.55 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
